Jane Henderson

Insider Reports History

Location
C/O Eleven Biotherapeutics, Inc., 215 First Street, Cambridge, MA
Signature
/s/ Matthew Batters, as attorney-in-fact for Jane Pritchett Henderson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane Henderson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apogee Therapeutics, Inc. Chief Financial Officer Common Stock 196K $13.7M $70.00 Nov 25, 2025 Direct
Akero Therapeutics, Inc. Director Common Stock 9.4K $446K $47.46 Aug 12, 2025 Direct
Adagio Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 175K Jan 30, 2022 Direct
Apogee Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 125K Dec 9, 2024 Direct
Sesen Bio, Inc. Director Stock Option 92.5K May 3, 2021 Direct
Akero Therapeutics, Inc. Director Stock Option (Right to Buy) 11.8K Aug 12, 2025 Direct
CARGO Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Aug 19, 2025 Direct
IVERIC bio, Inc. Director Common Stock 0 $39.45 Jul 11, 2023 Direct
IVERIC bio, Inc. Director Restricted Stock Units 0 Jul 11, 2023 Direct
IVERIC bio, Inc. Director Stock Option (Right to Buy) 0 $10.03 Jul 11, 2023 Direct

Insider Reports Filed by Jane Henderson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APGE Apogee Therapeutics, Inc. Nov 25, 2025 1 -$105K 4 Nov 28, 2025 Chief Financial Officer
APGE Apogee Therapeutics, Inc. Nov 14, 2025 1 -$130K 4 Nov 14, 2025 Chief Financial Officer
APGE Apogee Therapeutics, Inc. Nov 11, 2025 1 -$60K 4 Nov 13, 2025 Chief Financial Officer
CRGX CARGO Therapeutics, Inc. Aug 19, 2025 1 $0 4 Aug 19, 2025 Director
AKRO Akero Therapeutics, Inc. Aug 12, 2025 3 -$121K 4 Aug 12, 2025 Director
CRGX CARGO Therapeutics, Inc. Jun 18, 2025 1 $0 4 Jun 20, 2025 Director
AKRO Akero Therapeutics, Inc. Jun 3, 2025 1 $0 4 Jun 5, 2025 Director
APGE Apogee Therapeutics, Inc. Dec 9, 2024 1 $0 4 Dec 11, 2024 Chief Financial Officer
APGE Apogee Therapeutics, Inc. Aug 23, 2024 1 -$290K 4 Aug 23, 2024 Chief Financial Officer
AKRO Akero Therapeutics, Inc. Jun 8, 2024 1 $0 4 Jun 11, 2024 Director
CRGX CARGO Therapeutics, Inc. Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
CRGX CARGO Therapeutics, Inc. Jun 3, 2024 0 $0 3 Jun 6, 2024 Director
APGE Apogee Therapeutics, Inc. Dec 18, 2023 1 $0 4 Dec 20, 2023 Chief Financial Officer
APGE Apogee Therapeutics, Inc. Jul 13, 2023 0 $0 3/A Jul 17, 2023 Chief Financial Officer
ISEE IVERIC bio, Inc. Jul 11, 2023 8 $0 4 Jul 13, 2023 Director
AKRO Akero Therapeutics, Inc. Jun 23, 2023 1 $0 4 Jun 27, 2023 Director
AKRO Akero Therapeutics, Inc. Jun 16, 2023 4 -$1.89M 4 Jun 21, 2023 Director
ISEE IVERIC bio, Inc. May 17, 2023 1 $0 4 May 19, 2023 Director
ISEE IVERIC bio, Inc. May 11, 2023 2 $0 4 May 15, 2023 Director
AKRO Akero Therapeutics, Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
ISEE IVERIC bio, Inc. May 11, 2022 4 $0 4 May 13, 2022 Director
IVVD Adagio Therapeutics, Inc. Jan 30, 2022 1 $0 4 Feb 1, 2022 Chief Financial Officer
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 0 $0 3 Aug 5, 2021 Chief Financial Officer
AKRO Akero Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director
ISEE IVERIC bio, Inc. May 19, 2021 2 $0 4 May 20, 2021 Director
CARM Sesen Bio, Inc. May 3, 2021 1 $0 4 May 10, 2021 Director